# A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis

> **NCT00382213** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 210 (—)

## Conditions studied

- Atherosclerosis

## Interventions

- **DRUG:** Olmesartan medoxomil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00382213
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 210 (—)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00382213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00382213, "A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00382213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*